UPC (Universe Pharmaceuticals Inc. Class A Ordinary Shares) Stock Analysis - Hedge Fund Holdings
Universe Pharmaceuticals Inc. Class A Ordinary Shares (UPC) is a publicly traded Healthcare sector company. As of May 21, 2026, UPC trades at $2.76 with a market cap of $1.45M and a P/E ratio of 0.00. UPC moved +0.00% today. Year to date, UPC is -33.99%; over the trailing twelve months it is -55.22%. Its 52-week range spans $2.00 to $600.00. Rallies surfaces UPC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who owns UPC stock?
Hedge funds tracked by Rallies that own UPC include Two Sigma and Renaissance Technologies. The latest tracked quarter is Sep 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Universe Pharmaceuticals Inc. Class A Ordinary Shares.
UPC Key Metrics
Key financial metrics for UPC
Metric
Value
Price
$2.76
Market Cap
$1.45M
P/E Ratio
0.00
EPS
$0.00
Dividend Yield
0.33%
52-Week High
$600.00
52-Week Low
$2.00
Volume
3
Avg Volume
0
Revenue (TTM)
$0
Net Income
$0
Gross Margin
0.00%
Top Hedge Funds Holding UPC
Two Sigma holds 90.37K shares of UPC, changed +0.00% as of Sep 30, 2024.
Renaissance Technologies holds 39.27K shares of UPC, changed +0.00% as of Sep 30, 2024.
UPC analyst coverage data. Average price target: $0.00.
Common questions about UPC
Who owns UPC stock?
Hedge funds tracked by Rallies that own UPC include Two Sigma and Renaissance Technologies. The latest tracked quarter is Sep 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Universe Pharmaceuticals Inc. Class A Ordinary Shares.
Does Rallies show 13F holders for UPC?
Yes. Rallies tracks hedge fund and 13F ownership data for UPC, including fund names, share counts, latest tracked quarter, and position changes when available.
Is UPC research on Rallies investment advice?
No. Rallies provides research, data, and educational context for UPC. It does not provide personalized investment advice.
